您的位置: 首页 > 农业专利 > 详情页

Methods of treating cancer patients with farnesyl transferase inhibitors
专利权人:
KURA ONCOLOGY INC.
发明人:
Gualberto, Antonio,Scholz, Catherine
申请号:
NZ73685316
公开号:
NZ736853A
申请日:
2016.08.16
申请国别(地区):
NZ
年份:
2019
代理人:
摘要:
The present invention relates to the field of molecular biology and cancer biology. Specifically, the present invention relates to the uses of tipifarnib, a farnesyltransferase inhibitor (FTI), in the manufacture of a medicament for treating head and neck squamous cell carcinoma (HNSCC) in a selected population of subjects based their HRAS mutation status. Still more specifically, the HNSCC is at an advanced stage, metastatic, relapsed or refractory and is human papillomavirus-negative.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充